Mr. Vernon Eugene Andersen Jr., RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 341 W Bethalto Dr, Bethalto, IL 62010 Phone: 618-377-5356 Fax: 618-377-0159 |
Mrs. Kimberly Michelle Meador, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 172 E Mcarthur Dr, Bethalto, IL 62010 Phone: 618-258-0822 Fax: 618-258-1190 |
Dr. Erin Michelle Austin, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 68 N Bellwood Rd, Bethalto, IL 62010 Phone: 618-717-7051 Fax: 618-717-7052 |
Dr. David Libbra, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 172 E Mcarthur Dr, Bethalto, IL 62010 Phone: 618-258-0822 |
Debra J Taylor, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 172 E Mcarthur Dr, Bethalto, IL 62010 Phone: 618-259-7056 |
Rudy Mack, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 172 E Mcarthur Blvd, Bethalto, IL 62010 Phone: 618-258-0822 Fax: 618-258-1190 |
Aaron Burge, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 172 E Mcarthur Dr, Bethalto, IL 62010 Phone: 618-258-0822 |
Dr. Taylor June Maglasang Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 172 E Mcarthur Dr, Bethalto, IL 62010 Phone: 618-960-6908 |
Mr. William P Hale, RPH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 68 N Bellwood Rd, Bethalto, IL 62010 Phone: 618-377-2151 Fax: 618-377-7966 |
News Archive
Patients treated with targeted therapy for metastatic renal cell carcinoma may derive significant survival benefit from cytoreductive nephrectomy, particularly if their initial prognosis is good, study findings indicate.
DRG International, a leading international medical diagnostic company, will showcase the Newly Optimized DRG Saliva ELISA Assays at the 2016 AACC in Philadelphia, Pennsylvania from August 02-04.
The brain's center of reasoning and problem solving is among the last to mature, a new study graphically reveals. The decade-long magnetic resonance imaging (MRI) study of normal brain development, from ages 4 to 21, by researchers at NIH's National Institute of Mental Health (NIMH) and University of California Los Angeles (UCLA) shows that such "higher-order" brain centers, such as the prefrontal cortex, don't fully develop until young adulthood.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing potential best in class oncology and central nervous system therapeutics, today announced clinical results with its investigational new drug, Serdaxin®for the treatment of major depressive disorder.
› Verified 9 days ago